Delivery Order SPE2DB24D2205-SPE2DB25FEEBL
- Not listed
- The Defense Logistics Agency awarded a $26,579.88 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on September 2, 2025, with completion scheduled for September 3, 2025. This competitively awarded, firm fixed-price contract represents a small component of the vendor's extensive pharmaceutical supply operations supporting federal medical procurement. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $6,644.97 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine in oral syringe format (1.5 milliliter units). This firm fixed-price delivery order, executed on August 12, 2025, with an ultimate completion date of August 13, 2025, represents a competitively awarded contract with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,953.32 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5 mL) on September 22, 2025, with an ultimate completion date of September 23, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Rotarix Vaccine Oral Syringe 1.5ML, with a ceiling value of $6,750.09. This competitively awarded, firm fixed-price delivery order is scheduled for ultimate completion by August 5, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents no set-aside designation, indicating open competition among qualified vendors. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,959.21 to AmerisourceBergen Drug Corp for Rotarix vaccine in oral syringe format (1.5ml) on September 16, 2025, with completion scheduled for September 17, 2025. This competitively awarded, firm fixed-price delivery order was placed under no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,067.22 to AmerisourceBergen Drug Corp for the supply of Rotarix vaccine oral syringes (1.5mL) with a firm fixed price structure. The contract, which was competitively awarded with no set-aside designation, is scheduled for ultimate completion on April 25, 2025, one day after the award date of April 24, 2025. Performance will be fulfilled from AmerisourceBergen's facility located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $2,214.99 delivery order to AmerisourceBergen Drug Corp on September 2, 2025, for Rotarix vaccine oral syringes (1.5mL). This non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by September 3, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) valued at $12,491.82 under a firm fixed price contract type. The award was made on September 22, 2025, with an ultimate completion date of September 23, 2025, and the performance location is AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded with no set-aside designation, reflecting the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $2,481.40 to AmerisourceBergen Drug Corp for Rotarix vaccine in oral syringe format (1.5 mL) on July 8, 2025, with completion scheduled for July 9, 2025. This competitively awarded, firm fixed-price delivery order was placed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract required no set-aside...
- The Defense Logistics Agency awarded a $31,634 delivery order to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5mL) on September 29, 2025, with a completion date of September 30, 2025. This competitively awarded, firm fixed-price delivery order was issued without set-aside designation and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The contract will be performed at the contractor's corporate office...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEEBLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $7,383.30 to AmerisourceBergen Drug Corp for Rotarix vaccine oral syringes (1.5ML) on June 25, 2025, with an ultimate completion date of June 26, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC functions as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies, including vaccines, specialty medications, brand-name and generic drugs, and medical devices to support military healthcare programs worldwide. The contract supports customers including the Defense Health Agency and U.S. Coast Guard through a flexible procurement mechanism aligned with DLA's strategic medical supply chain initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.4k | 6/25/25 |